Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A08313 | 32156377 | Food Res Int | Effect of okra fruit powder supplementation on metabolic syndrome and gut microbiota diversity in high fat diet-induced obese mice. | 2019 | Details |
| A08314 | 32156227 | Curr Pharm Des | Modifiers of Liver-Related Manifestation in the Course of NAFLD. | 2020 | Details |
| A08315 | 32156140 | Ann Palliat Med | Association between non-alcoholic fatty liver disease and silent carotid plaque in Chinese aged population: a cross-sectional study. | 2020 | Details |
| A08316 | 32155178 | PLoS One | Gender differences in diet-induced steatotic disease in Cyp2b-null mice. | 2020 | Details |
| A08317 | 32154399 | Heliyon | The advantages and disadvantages of sleeve gastrectomy; clinical laboratory to bedside review. | 2020 | Details |
| A08318 | 32153507 | Front Endocrinol (Lausanne) | Effect of Weight Loss Medications on Hepatic Steatosis and Steatohepatitis: A Systematic Review. | 2020 | Details |
| A08319 | 32153044 | J Gastroenterol Hepatol | Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels. | 2020 | Details |
| A08320 | 32152904 | Indian J Gastroenterol | Computed tomography-based evaluation of segmental variation of liver density and its implications. | 2020 | Details |
| A08321 | 32152903 | Indian J Gastroenterol | Epidemiology of non-alcoholic fatty liver disease in Asia. | 2020 | Details |
| A08322 | 32152902 | Indian J Gastroenterol | Treatment of non-alcoholic fatty liver disease - Current perspectives. | 2020 | Details |
| A08323 | 32152677 | Surg Endosc | Impact of laparoscopic sleeve gastrectomy on fibrosis stage in patients with child-A NASH-related cirrhosis. | 2020 | Details |
| A08324 | 32152511 | Eur J Clin Nutr | Association of grip strength with non-alcoholic fatty liver disease: investigation of the roles of insulin resistance and inflammation as mediators. | 2020 | Details |
| A08325 | 32152478 | Nat Rev Gastroenterol Hepatol | Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. | 2020 | Details |
| A08326 | 32151955 | Int Immunopharmacol | Anti-toll-like receptor 2 antibody ameliorates hepatic injury, inflammation, fibrosis and steatosis in obesity-related metabolic disorder rats via regulating MAPK and NF-κB pathways. | 2020 | Details |
| A08327 | 32151660 | Metabolism | Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis. | 2020 | Details |
| A08328 | 32151552 | Surg Obes Relat Dis | Management of nonalcoholic fatty liver disease and the role of bariatric surgery: a brief review for surgeons. | 2020 | Details |
| A08329 | 32151020 | Nutrients | Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A08330 | 32150756 | Hepatology | N6 -Methyladenosine Reader Protein YT521-B Homology Domain-Containing 2 Suppresses Liver Steatosis by Regulation of mRNA Stability of Lipogenic Genes. | 2020 | Details |
| A08331 | 32150306 | J Gastroenterol Hepatol | Endogenous ethanol produced by intestinal bacteria induces mitochondrial dysfunction in non-alcoholic fatty liver disease. | 2020 | Details |
| A08332 | 32150108 | Medicine (Baltimore) | Effects of high-intensity interval and moderate-intensity continuous aerobic exercise on diabetic obese patients with nonalcoholic fatty liver disease: A comparative randomized controlled trial. | 2020 | Details |
| A08333 | 32150036 | Transplantation | Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C. | 2020 | Details |
| A08334 | 32149781 | Am J Gastroenterol | Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08335 | 32149276 | Food Chem X | Current intakes of trans-palmitoleic (trans-C16:1 n-7) and trans-vaccenic (trans-C18:1 n-7) acids in France are exclusively ensured by ruminant milk and ruminant meat: A market basket investigation. | 2020 | Details |
| A08336 | 32149275 | JHEP Rep | Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism. | 2019 | Details |
| A08337 | 32149099 | Biomed Res Int | Liraglutide Attenuates Nonalcoholic Fatty Liver Disease by Modulating Gut Microbiota in Rats Administered a High-Fat Diet. | 2020 | Details |
| A08338 | 32148418 | J Ginseng Res | Ameliorative effects of black ginseng on nonalcoholic fatty liver disease in free fatty acid-induced HepG2 cells and high-fat/high-fructose diet-fed mice. | 2019 | Details |
| A08339 | 32148405 | J Ginseng Res | Ginseng-plus-Bai-Hu-Tang ameliorates diet-induced obesity, hepatic steatosis, and insulin resistance in mice. | 2018 | Details |
| A08340 | 32147742 | Acta Derm Venereol | Molecular Genetics of Keratinization Disorders - What's New About Ichthyosis. | 2020 | Details |
| A08341 | 32147363 | J Hepatol | Newly identified peptide hormone inhibits intestinal fat absorption and improves NAFLD through its receptor GPRC6A. | 2020 | Details |
| A08342 | 32147362 | J Hepatol | Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials. | 2020 | Details |
| A08343 | 32147361 | J Hepatol | Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH. | 2020 | Details |
| A08344 | 32147318 | Peptides | Glucagon-based therapy: Past, present and future. | 2020 | Details |
| A08345 | 32147076 | Complement Ther Med | Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver disease: A randomized, controlled trial. | 2019 | Details |
| A08346 | 32147075 | Complement Ther Med | Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial. | 2020 | Details |
| A08347 | 32146704 | Adv Ther | Managing NAFLD in Type 2 Diabetes: The Effect of Lifestyle Interventions, a Narrative Review. | 2020 | Details |
| A08349 | 32146441 | J Pediatr Endocrinol Metab | Utility of MR proton density fat fraction and its correlation with ultrasonography and biochemical markers in nonalcoholic fatty liver disease in overweight adolescents. | 2020 | Details |
| A08350 | 32146412 | Sci Total Environ | Non-linear association of serum molybdenum and linear association of serum zinc with nonalcoholic fatty liver disease: Multiple-exposure and Mendelian randomization approach. | 2020 | Details |
| A08351 | 32145387 | Prostaglandins Other Lipid Mediat | Lipocalin-type prostaglandin D2 synthase deletion induces dyslipidemia and non-alcoholic fatty liver disease. | 2020 | Details |
| A08352 | 32145332 | J Ethnopharmacol | Promising therapeutic use of Baccharis trimera (less.) DC. as a natural hepatoprotective agent against hepatic lesions that are caused by multiple risk factors. | 2020 | Details |
| A08353 | 32145306 | Life Sci | Differential metabolic and hepatic transcriptome responses of two miniature pig breeds to high dietary cholesterol. | 2020 | Details |
| A08354 | 32145261 | J Hepatol | A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank. | 2020 | Details |
| A08355 | 32145256 | J Hepatol | Update on NAFLD genetics: From new variants to the clinic. | 2020 | Details |
| A08356 | 32145145 | Liver Int | Targeting ferroptosis alleviates methionine-choline deficient (MCD)-diet induced NASH by suppressing liver lipotoxicity. | 2020 | Details |
| A08357 | 32145139 | BJOG | Overweight and obesity status from the prenatal period to adolescence and its association with non-alcoholic fatty liver disease in young adults: cohort study. | 2020 | Details |
| A08358 | 32145072 | Hepatology | Transcriptional Dynamics of Hepatic Sinusoid-Associated Cells After Liver Injury. | 2020 | Details |
| A08359 | 32144419 | J Clin Endocrinol Metab | Glycemic Measures and Development and Resolution of Nonalcoholic Fatty Liver Disease in Nondiabetic Individuals. | 2020 | Details |
| A08360 | 32144313 | Sci Rep | Carbohydrate response element binding protein (ChREBP) correlates with colon cancer progression and contributes to cell proliferation. | 2020 | Details |
| A08361 | 32143931 | J Pediatr | Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study. | 2020 | Details |
| A08362 | 32143904 | Pathol Res Pract | The significance of IL-28B and CK-18 M30 levels in the diagnosis of non-alcoholic steatohepatitis in SD rats. | 2020 | Details |
| A08363 | 32143527 | Nutrients | The Effects of Endoplasmic-Reticulum-Resident Selenoproteins in a Nonalcoholic Fatty Liver Disease Pig Model Induced by a High-Fat Diet. | 2020 | Details |
| A08364 | 32143184 | EBioMedicine | Compounds that modulate AMPK activity and hepatic steatosis impact the biosynthesis of microRNAs required to maintain lipid homeostasis in hepatocytes. | 2020 | Details |
| A08365 | 32143076 | Chemosphere | Differential mechanisms regarding triclosan vs. bisphenol A and fluorene-9-bisphenol induced zebrafish lipid-metabolism disorders by RNA-Seq. | 2020 | Details |
| A08366 | 32142998 | Diabetes Metab Syndr | rs7903146 (C/T) polymorphism of Transcription factor 7 like 2 (TCF7L-2) gene is independently associated with non-alcoholic fatty liver disease in Asian Indians. | 2020 | Details |
| A08367 | 32141917 | Am J Gastroenterol | Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk. | 2020 | Details |
| A08368 | 32141825 | Turk J Gastroenterol | Analysis of correlation between liver fat fraction and AST and ALT levels in overweight and obese children by using new magnetic resonance imaging technique. | 2020 | Details |
| A08370 | 32140062 | Int J Biol Sci | Aldehyde Dehydrogenase, Liver Disease and Cancer. | 2020 | Details |
| A08371 | 32139740 | Sci Rep | Odontogenic infection by Porphyromonas gingivalis exacerbates fibrosis in NASH via hepatic stellate cell activation. | 2020 | Details |
| A08372 | 32139603 | BMJ Open Diabetes Res Care | Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels. | 2020 | Details |
| A08373 | 32139507 | J Biol Chem | The balance of protein farnesylation and geranylgeranylation during the progression of nonalcoholic fatty liver disease. | 2020 | Details |
| A08374 | 32138869 | Ann Hepatol | Antiretroviral Therapies for Human Immunodeficiency Virus and Liver Disease: Challenges and opportunities. | 2021 | Details |
| A08375 | 32138796 | Br J Nutr | Food groups and the likelihood of non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2020 | Details |
| A08376 | 32138593 | Prion | The role of cellular prion protein in lipid metabolism in the liver. | 2020 | Details |
| A08377 | 32135582 | Gut Liver | Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus. | 2020 | Details |
| A08378 | 32135539 | Dig Dis | Sarcopenia Is a New Risk Factor of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease. | 2020 | Details |
| A08379 | 32135178 | J Hepatol | Inhibition of PU.1 ameliorates metabolic dysfunction and non-alcoholic steatohepatitis. | 2020 | Details |
| A08380 | 32134732 | J Basic Clin Physiol Pharmacol | Silymarin: not just another antioxidant. | 2020 | Details |
| A08381 | 32133676 | Aliment Pharmacol Ther | Modelling NAFLD disease burden in four Asian regions-2019-2030. | 2020 | Details |
| A08382 | 32132708 | Nature | Glucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis. | 2020 | Details |
| A08384 | 32131439 | Cells | Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis. | 2020 | Details |
| A08385 | 32130675 | Hepatol Int | The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis. | 2020 | Details |
| A08388 | 32130386 | Rev Assoc Med Bras (1992) | Non-alcoholic fatty liver disease in patients infected with human immunodeficiency virus: a systematic review. | 2020 | Details |
| A08389 | 32129747 | Med Sci (Paris) | [Endoplasmic reticulum stress response and pathogenesis of non-alcoholic steatohepatitis]. | 2020 | Details |
| A08390 | 32128995 | Pediatr Obes | Effects of a carbohydrate-restricted diet on hepatic lipid content in adolescents with non-alcoholic fatty liver disease: A pilot, randomized trial. | 2020 | Details |
| A08391 | 32128921 | NMR Biomed | The relationship between liver triglyceride composition and proton density fat fraction as assessed by 1 H MRS. | 2020 | Details |
| A08392 | 32128904 | J Intern Med | Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016. | 2020 | Details |
| A08393 | 32128893 | J Gastroenterol Hepatol | Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway. | 2020 | Details |
| A08394 | 32128882 | J Gastroenterol Hepatol | Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B-related hepatocellular carcinoma. | 2020 | Details |
| A08395 | 32128321 | Open Forum Infect Dis | Sex Hormone-Binding Globulin Levels Are Inversely Associated With Nonalcoholic Fatty Liver Disease in HIV-Infected and -Uninfected Men. | 2019 | Details |
| A08396 | 32126269 | Biochim Biophys Acta Mol Basis Dis | Chemical hypoxia induces pro-inflammatory signals in fat-laden hepatocytes and contributes to cellular crosstalk with Kupffer cells through extracellular vesicles. | 2020 | Details |
| A08397 | 32126212 | Toxicol Appl Pharmacol | Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells. | 2020 | Details |
| A08398 | 32125756 | Liver Int | PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings. | 2020 | Details |
| A08399 | 32124935 | Int J Mol Med | CYP4A11 is involved in the development of nonalcoholic fatty liver disease via ROS‑induced lipid peroxidation and inflammation. | 2020 | Details |
| A08400 | 32124690 | Curr Pharm Des | Epidemiology of Non-alcoholic Fatty Liver Disease in North America. | 2020 | Details |
| A08401 | 32124686 | Curr Med Chem | The Effect of CB1 Antagonism on Hepatic Oxidative/Nitrosative Stress and Inflammation in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A08402 | 32124651 | Expert Rev Gastroenterol Hepatol | The effects of epigenetic modification on the occurrence and progression of liver diseases and the involved mechanism. | 2020 | Details |
| A08404 | 32124221 | Obes Surg | Are Noninvasive Methods Comparable to Liver Biopsy in Postoperative Patients After Roux-en-Y Gastric Bypass? | 2020 | Details |
| A08405 | 32124219 | Obes Surg | Obstructive Sleep Apnea and Non-alcoholic Fatty Liver Disease in Obese Patients Undergoing Bariatric Surgery. | 2020 | Details |
| A08406 | 32124215 | Obes Surg | Effects of Laparoscopic Sleeve Gastrectomy on Non-Alcoholic Steatohepatitis and Liver Fibrosis in Japanese Patients with Severe Obesity. | 2020 | Details |
| A08407 | 32124212 | Obes Surg | Evaluation of Liver Function Tests and Risk Score Assessment to Screen Patients for Significant Liver Disease Prior to Bariatric and Metabolic Surgery. | 2020 | Details |
| A08408 | 32124081 | J Gastroenterol | Fatty acid-driven modifications in T-cell profiles in non-alcoholic fatty liver disease patients. | 2020 | Details |
| A08409 | 32123832 | FASEB Bioadv | Identification of hepatic NPC1L1 as an NAFLD risk factor evidenced by ezetimibe-mediated steatosis prevention and recovery. | 2019 | Details |
| A08410 | 32123241 | Sci Rep | Self-rated health and risk of incident non-alcoholic fatty liver disease: A cohort study. | 2020 | Details |
| A08411 | 32123238 | Sci Rep | Association between Fatty Liver Index and Periodontitis: the Korea National Health and Nutrition Examination Survey. | 2020 | Details |
| A08413 | 32121602 | Nutrients | Citrus Peel Extract Ameliorates High-Fat Diet-Induced NAFLD via Activation of AMPK Signaling. | 2020 | Details |
| A08414 | 32121253 | Int J Mol Sci | Estrogen-Related Receptor Alpha: An Under-Appreciated Potential Target for the Treatment of Metabolic Diseases. | 2020 | Details |
| A08417 | 32119738 | J Nutr | One-Carbon Metabolism in Fatty Liver Disease and Fibrosis: One-Carbon to Rule Them All. | 2020 | Details |
| A08418 | 32118853 | Eur J Gastroenterol Hepatol | A nomogram for discrimination of non-alcoholic fatty liver disease in patients with chronic hepatitis B. | 2021 | Details |
| A08420 | 32118201 | JHEP Rep | Limitations of non-invasive tests for assessment of liver fibrosis. | 2020 | Details |
| A08422 | 32117693 | Euroasian J Hepatogastroenterol | High Prevalence of Wilson's Diseases with Low Prevalence of Kayser-Fleischer Rings among Patients with Cryptogenic Chronic Liver Diseases in Bangladesh. | 2022 | Details |
| A08423 | 32116684 | Front Pharmacol | Corilagin Alleviates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced C57BL/6 Mice by Ameliorating Oxidative Stress and Restoring Autophagic Flux. | 2020 | Details |